clinical study on the efficacy of infiltrative echo-guided therapy with hyaluronic acid (500-730 KDa) (HYALGAN®) versus saline solution in the conservative treatment of Achilles tendinopathy. Subjects will be randomly assigned to one of these two groups of treatment. Both evaluator and patients are unaware of the treatment assigned. In the open label extension, patients with persistent pain can receive a second cycle of Hyalgan.
- Registry ID
- EUCTR2013-004117-40
- Source registry
- EUCTR
- Status
- Prematurely Ended
- Phase
- PHASE3
- Sponsor
- Fidia Farmaceutici SpA
- Start date
- 2013-12-06
- Completion date
- 2016-02-16
- Last update
- 2026-08-16
Conditions
Summary
Primary objective of this trial is to evaluate, after 28 days from the beginning of therapy, the efficacy of the infiltrative treatment with hyaluronic acid versus saline solution on pain and physical function, using the VISA-A questionnaire, in patients with subacute or chronic tendinitis of Achilles tendon
Locations
View on source registry